Thymoma PBMC
About: Thymoma PBMC - IRB-consented PBMC samples collected from donors diagnosed with Thymoma. Suitable for understanding immune dysregulation and T cell repertoire changes in thymic tumors.
Thymoma PBMC
Thymoma PBMC is collected from IRB-consented donors diagnosed with clinically confirmed Thymoma. These peripheral blood mononuclear cell (PBMC) samples are ideal for understanding immune dysregulation and T cell repertoire changes in thymic tumors. These PBMCs are useful for immunophenotyping, TCR sequencing, and studying autoimmune paraneoplastic phenomena associated with thymoma.
Product Features
- Cryopreserved, clinically verified Thymoma samples
- Cryopreserved to ensure stability and long-term storage
- Research Use Only (RUO)
De-identified Donor Data
- Clinically confirmed Thymoma diagnosis
- Donor demographics: age, sex assigned at birth, ethnicity
- Medical and treatment history available when applicable
Applications
- Understanding immune dysregulation and T cell repertoire changes in thymic tumors
- Biomarker discovery and validation
- Transcriptomic, proteomic, or functional studies
- Custom assay development and disease modeling
Compliance and Quality
- IRB-approved collection and electronic informed consent
- HIPAA-compliant donor data handling
Ordering and Customization
Thymoma PBMC is available in standard and custom volumes. Contact learnmore@sanguinebio.com for international requests or documentation needs.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/
1 Answer
YES – Certificate of analysis is available upon request.
1 Answer
Lead times vary from ready to ship inventory to prospective studies.
1 Answer
International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.
1 Answer
We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/
1 Answer
You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/
1 Answer
NO – no minimum order requirements.
1 Answer
For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com
1 Answer
YES – Fresh leukopaks can be delivered same day in select locations. Often, leukopaks are shipped same day as collection, thus arriving next day.
1 Answer
Contact learnmore@sanguinebio.com for current inventory. The website states “over 150 verified-conditions from ready-to-ship to prospective collections.” View our ready to ship products: https://sanguinebio.com/products/?pro_inventory=inventory
1 Answer
YES – Matched samples across multiple matrices are available, including synovial fluid are available.
0 Answer
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.